From: MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma
Features | No. of patients | MEX3A expression | P value | |
---|---|---|---|---|
Low | High | |||
All patients | 62 | 34 | 28 | |
Age (years) | 0.462 | |||
< 67 | 30 | 15 | 15 | |
≥ 67 | 32 | 19 | 13 | |
Gender | 0.704 | |||
Male | 36 | 19 | 17 | |
Female | 26 | 15 | 11 | |
Lymph node number | 0.302 | |||
≤ 6 | 30 | 23 | 7 | |
> 6 | 24 | 7 | 17 | |
Lymph node positive | 0.687 | |||
≤ 0 | 34 | 18 | 16 | |
> 0 | 24 | 14 | 10 | |
Tumor size | 0.467 | |||
< 4 cm | 23 | 14 | 9 | |
≥ 4 cm | 39 | 20 | 19 | |
Grade | 0.023 | |||
I | 1 | 0 | 1 | |
II | 32 | 23 | 9 | |
III | 29 | 11 | 18 | |
AJCC Stage | 0.782 | |||
1 | 5 | 3 | 2 | |
2 | 44 | 26 | 18 | |
4 | 4 | 2 | 2 | |
T stage | 0.936 | |||
T1 | 2 | 1 | 1 | |
T2 | 7 | 4 | 3 | |
T3 | 37 | 21 | 16 | |
N stage | 0.593 | |||
N0 | 34 | 18 | 16 | |
N1 | 25 | 15 | 10 |